Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1655
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18650858 | METHOD TO INHIBIT FUNCTION OF 5-ALPHA REDUCTASE IN THE SCALP SKIN THROUGH COMBINATION OF PLANT-DERIVED EXTRACTS IN A COSMETIC COMPOSITION | Non-Final OA | KILGOURMD, INC |
| 18645866 | SPIDER WEB ERADICATION AND SPIDER REPELLANT COMPOUND AND METHODS OF USE | Non-Final OA | DALRAY, LLC. |
| 18639308 | OVER-THE-COUNTER TRADITIONAL CHINESE MEDICINE FOR WEIGHT LOSS | Non-Final OA | Chongqing Kangershou Biopharmaceutical Technology Co., Ltd |
| 18012321 | SALVIA PLEBIA AND SCUTELLARIAE RADIX COMPOUND ACNE CREAM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Non-Final OA | SOOCHOW UNIVERSITY |
| 18444601 | METHOD AND COMPOSITIONS FOR THE USE OF BOTANICAL EXTRACTS IN THE TREATMENT OF VIRAL INFECTIONS | Non-Final OA | Aviratek Biomedical Solutions LLC |
| 18682066 | PEDICULICIDAL COMPOSITION | Non-Final OA | OYSTERSHELL NV |
| 18518455 | METHOD FOR IMPROVING SKIN COMPLEXION BY USING ROSA CANINA EXTRACT | Final Rejection | TCI CO., LTD. |
| 18544023 | CONCOMITANT ADMINISTRATION OF OILS FOR MANAGING NEURODEGENERATIVE DISEASES AND DEVELOPMENTAL DISORDERS | Non-Final OA | UNIVERSIDAD DE CUENCA |
| 18566993 | USES OF BLETILLA FORMOSANA EXTRACT FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DYSREGULATED ACTIVATION OF NEUTROPHILS | Non-Final OA | Chang Gung University of Science and Technology |
| 18565976 | INSECTICIDAL COMPOSITION FOR AGRICULTURAL OR HORTICULTURAL USE AND METHOD OF CONTROLLING AGRICULTURAL OR HORTICULTURAL PEST | Non-Final OA | SDS BIOTECH K.K |
| 18277006 | NOVEL ARTHRITIS EMULGEL COMPOSITION AND ITS PREPARATION PROCESS | Non-Final OA | NOKHA TRADING LLP |
| 18261203 | METHODS AND PLATFORMS FOR PROMOTING ANTIGEN-SPECIFIC TOLERANCE IN THE TREATMENT OF TYPE 1 DIABETES AND GRAFT REJECTION AND COMPOSITIONS RELATING THERETO | Non-Final OA | University of Maryland, Baltimore |
| 18006463 | METHOD FOR PRODUCING A PURIFIED CANNABINOID EXTRACT, AND A PURIFIED CANNABINOID EXTRACT OBTAINED THEREFROM | Non-Final OA | PURCANN PHARMA INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy